Spots Global Cancer Trial Database for stage ivb colorectal cancer

Every month we try and update this database with for stage ivb colorectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors	NCT02650635	Colorectal Aden... Metastatic Panc... Recurrent Breas... Recurrent Color... Recurrent Melan... Recurrent Non-S... Recurrent Pancr... Recurrent Renal... Solid Neoplasm Stage IV Breast... Stage IV Non-Sm... Stage IV Renal ... Stage IV Skin M... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr...	Cyclophosphamid... Laboratory Biom... Pegfilgrastim Pharmacological... TLR8 Agonist VT...	18 Years -	Mayo Clinic
Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer	NCT02573220	Stage IVA Color... Stage IVB Color...	Cetuximab Fluorouracil Irinotecan Hydr... Leucovorin Calc...	18 Years -	University of Chicago
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	NCT03095781	Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa...	XL888 Pembrolizumab	18 Years -	Emory University
Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer	NCT02573220	Stage IVA Color... Stage IVB Color...	Cetuximab Fluorouracil Irinotecan Hydr... Leucovorin Calc...	18 Years -	University of Chicago
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors	NCT02650635	Colorectal Aden... Metastatic Panc... Recurrent Breas... Recurrent Color... Recurrent Melan... Recurrent Non-S... Recurrent Pancr... Recurrent Renal... Solid Neoplasm Stage IV Breast... Stage IV Non-Sm... Stage IV Renal ... Stage IV Skin M... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr...	Cyclophosphamid... Laboratory Biom... Pegfilgrastim Pharmacological... TLR8 Agonist VT...	18 Years -	Mayo Clinic
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery	NCT03087591	Metastatic Mali... Metastatic Soli... Recurrent Color... Recurrent Pancr... Recurrent Solid... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable So...	Laboratory Biom... siRNA-transfect...	18 Years -	Wake Forest University Health Sciences
Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver	NCT03005002	Metastatic Carc... MLH1 Gene Mutat... MSH6 Gene Mutat... PMS2 Gene Mutat... Stage IV Colore... Stage IVA Color... Stage IVB Color...	Durvalumab Laboratory Biom... Tremelimumab	19 Years -	City of Hope Medical Center
FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer	NCT02508077	Recurrent Color... Stage IVA Color... Stage IVB Color...	Fluorouracil Irinotecan Hydr... Laboratory Biom... Leucovorin Calc... Panitumumab	18 Years -	City of Hope Medical Center
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer	NCT04044430	Metastatic Colo... Metastatic Colo... Metastatic Micr... Metastatic Rect... Stage III Colon... Stage III Color... Stage III Recta... Stage IIIA Colo... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Colo... Stage IIIC Rect... Stage IV Colon ... Stage IV Colore... Stage IV Rectal... Stage IVA Colon... Stage IVA Color... Stage IVA Recta... Stage IVB Colon... Stage IVB Color... Stage IVB Recta... Stage IVC Colon... Stage IVC Color... Stage IVC Recta...	Binimetinib Encorafenib Nivolumab Questionnaire A...	18 Years -	University of California, San Francisco
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	NCT03095781	Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa...	XL888 Pembrolizumab	18 Years -	Emory University
Programs To Support You During Chemotherapy	NCT02489422	Depression Fatigue Stage IIA Color... Stage IIB Color... Stage IIC Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IVA Color... Stage IVB Color... Pancreatic Canc... Esophageal Canc... Appendix Cancer Stomach Cancer Gallbladder Can... Liver Cancer Small Intestine... Large Intestine... Anal Cancer Biliary Tract C... Gastrointestina...	Laboratory Biom... Questionnaire A... Daily Survey Ad... Yoga Skills Tra... Attention Contr... Actigraphy Asse...	21 Years -	Wake Forest University Health Sciences
Glutamine PET Imaging Colorectal Cancer	NCT03275974	RAS Wild Type Stage IV Colore... Stage IVA Color... Stage IVB Color...	Carbon C 11 Glu... Fluorine F 18 L... Positron Emissi... Blood Draw	18 Years -	M.D. Anderson Cancer Center
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery	NCT02511821	Stage I Adult L... Stage I Colorec... Stage IA Gastri... Stage IA Pancre... Stage IB Gastri... Stage IB Pancre... Stage II Adult ... Stage IIA Color... Stage IIA Gastr... Stage IIA Pancr... Stage IIB Color... Stage IIB Gastr... Stage IIB Pancr... Stage IIC Color... Stage III Pancr... Stage IIIA Adul... Stage IIIA Colo... Stage IIIA Gast... Stage IIIB Adul... Stage IIIB Colo... Stage IIIB Gast... Stage IIIC Adul... Stage IIIC Colo... Stage IIIC Gast... Stage IV Gastri... Stage IVA Color... Stage IVA Liver... Stage IVA Pancr... Stage IVB Color... Stage IVB Liver... Stage IVB Pancr...	Computer-Assist... Vivofit watch Quality-of-Life... Questionnaire A...	21 Years -	City of Hope Medical Center
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)	NCT02728596	Febrile Neutrop... Stage 0 Breast ... Stage 0 Colorec... Stage 0 Non-Sma... Stage I Colorec... Stage IA Breast... Stage IA Non-Sm... Stage IB Breast... Stage IB Non-Sm... Stage IIA Breas... Stage IIA Color... Stage IIA Non-S... Stage IIB Breas... Stage IIB Color... Stage IIB Non-S... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIC Brea... Stage IIIC Colo... Stage IV Breast... Stage IV Non-Sm... Stage IVA Color... Stage IVB Color...	Preventive Inte... Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners	NCT03112668	Malignant Femal... Malignant Hepat... Partner Stage III Breas... Stage III Cervi... Stage III Color... Stage III Lung ... Stage III Prost... Stage III Skin ... Stage III Uteri... Stage IIIA Brea... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Skin... Stage IIIA Uter... Stage IIIB Brea... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Skin... Stage IIIB Uter... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Skin... Stage IIIC Uter... Stage IV Breast... Stage IV Cervic... Stage IV Colore... Stage IV Lung C... Stage IV Prosta... Stage IV Skin M... Stage IV Uterin... Stage IVA Cervi... Stage IVA Color... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Color... Stage IVB Uteri...	Cognitive Behav... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy	NCT02960282	Metastatic Carc... Stage IV Colore... Stage IVA Color... Stage IVB Color...	Biospecimen Col... Laboratory Biom...	18 Years -	University of Southern California
Programs To Support You During Chemotherapy	NCT02489422	Depression Fatigue Stage IIA Color... Stage IIB Color... Stage IIC Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IVA Color... Stage IVB Color... Pancreatic Canc... Esophageal Canc... Appendix Cancer Stomach Cancer Gallbladder Can... Liver Cancer Small Intestine... Large Intestine... Anal Cancer Biliary Tract C... Gastrointestina...	Laboratory Biom... Questionnaire A... Daily Survey Ad... Yoga Skills Tra... Attention Contr... Actigraphy Asse...	21 Years -	Wake Forest University Health Sciences
Programs To Support You During Chemotherapy	NCT02489422	Depression Fatigue Stage IIA Color... Stage IIB Color... Stage IIC Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IVA Color... Stage IVB Color... Pancreatic Canc... Esophageal Canc... Appendix Cancer Stomach Cancer Gallbladder Can... Liver Cancer Small Intestine... Large Intestine... Anal Cancer Biliary Tract C... Gastrointestina...	Laboratory Biom... Questionnaire A... Daily Survey Ad... Yoga Skills Tra... Attention Contr... Actigraphy Asse...	21 Years -	Wake Forest University Health Sciences
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)	NCT02728596	Febrile Neutrop... Stage 0 Breast ... Stage 0 Colorec... Stage 0 Non-Sma... Stage I Colorec... Stage IA Breast... Stage IA Non-Sm... Stage IB Breast... Stage IB Non-Sm... Stage IIA Breas... Stage IIA Color... Stage IIA Non-S... Stage IIB Breas... Stage IIB Color... Stage IIB Non-S... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIC Brea... Stage IIIC Colo... Stage IV Breast... Stage IV Non-Sm... Stage IVA Color... Stage IVB Color...	Preventive Inte... Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer	NCT02837263	Colorectal Canc... Colorectal Aden... Stage IVA Color... Stage IVB Color... Metastatic Carc...	Stereotactic bo... Pembrolizumab	18 Years -	University of Wisconsin, Madison
Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery	NCT02713373	Recurrent Color... Stage IVA Color... Stage IVB Color...	Cetuximab Laboratory Biom... Pembrolizumab	18 Years -	Roswell Park Cancer Institute
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer	NCT03800602	Colorectal Aden... Metastatic Micr... Refractory Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... Stage IVC Color... Colorectal Canc...	Metformin Nivolumab	18 Years -	Emory University
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	NCT03095781	Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa...	XL888 Pembrolizumab	18 Years -	Emory University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: